Yan Peng | Nanotheranostics | Best Researcher Award

Dr. Yan Peng | Nanotheranostics | Best Researcher Award

Vice Professor | Fuyang Normal University | China

Dr. Yan Peng is a dynamic molecular genetics researcher whose work centers on genetic testing, RNA imaging, and fluorogenic aptamer technologies. With a growing scholarly footprint reflected in 73 Scopus citations, 7 indexed documents, and an h-index of 5, her research advances innovative molecular tools for visualizing and quantifying RNA and protein interactions in living cellular environments. Her publication portfolio demonstrates a sustained commitment to high-impact research in analytical chemistry, nucleic acid engineering, and functional genomics. Dr. Yan Peng has contributed significantly to the development of RNA-based imaging platforms, notably pioneering strategies for in situ mRNA visualization through split aptamers and protein-based reporters. Her research extends into genetically encoded fluorogenic allosteric aptamers for live-cell RNA tracking, with articles featured in top-tier journals such as Analytical Chemistry, Analytica Chimica Acta, and Nucleic Acids Research. A notable dimension of her work involves the design of organelle-targeted fluorogen-activating aptamers, enabling precise spatial mapping of endogenous RNA molecules within complex biological systems. Additionally, she has collaborated on influential studies exploring RNA-guided PROTAC activation and functional retention in frame-shifted proteins, contributing new insights to the fields of RNA biology and protein engineering. Dr. Yan Peng has secured multiple competitive research grants as Principal Investigator, including national, provincial, and institutional funding supporting advancements in molecular diagnostics, RNA imaging technologies, and interdisciplinary medical research. Her funded projects span initiatives from the Ministry of Education’s Industry–University Collaborative Education Program and several Anhui Province scientific research programs, collectively amounting to substantial support for her expanding research endeavors. Her contributions reflect strong innovation in nucleic acid engineering, live-cell imaging methodologies, and translational molecular technologies. Dr. Yan Peng’s work continues to shape emerging directions in genetic testing, RNA visualization, and molecular analytical systems, establishing her as an influential scholar within the molecular genetics and biomedical research community.

Profiles: Scopus | ORCID

Featured Publications

1. Peng, Y., Ai, X. L., Yuan, Y. Y., Dong, J., Cui, X., Du, F., Huang, X., & Tang, Z. (2022). Organelle-targeted imaging based on fluorogen-activating RNA aptamers in living cells. Analytica Chimica Acta, 1209, 339816. https://doi.org/10.1016/j.aca.2022.339816

2. Peng, Y., Huang, X., Huang, T. F., Du, F., Cui, X., & Tang, Z. (2022). Combining protein and RNA quantification to evaluate promoter activity by using dual-color fluorescent reporting systems. Bioscience Reports, 41(9), BSR20211525. https://doi.org/10.1042/BSR20211525

3. Xu, Y., Fu, D. Q., Yuan, Y., Peng, Y., Dong, J., Du, F., Huang, X., Liu, G. X., Chen, X. H., Wang, Q. W., & Tang, Z. (2023). A heterobifunctional molecule recruits cereblon to an RNA scaffold and activates its PROTAC function. Cell Reports Physical Science, 3(10), 101064. https://doi.org/10.1016/j.xcrp.2023.101064

4. Huang, X., Chen, R., Sun, M. L., Peng, Y., Pu, Q. L., Yuan, Y., Chen, G. Y., Dong, J., Du, F., Cui, X., & Tang, Z. (2021). Frame-shifted proteins of a given gene retain the same function. Nucleic Acids Research, 48(8), 4396–4404. https://doi.org/10.1093/nar/gkaa169

5. Huang, X., Zhao, Y. Y., Pu, Q. L., Liu, G. X., Peng, Y., Wang, F., Chen, G. Y., Sun, M. L., Du, F., Cui, X., & Tang, Z. (2020). Intracellular selection of trans-cleaving hammerhead ribozymes. Nucleic Acids Research, 47(5), 2514–2522. https://doi.org/10.1093/nar/gky1191

Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Dr. Stavros Melemenidis , Stanford University School of Medicine , United States

Stavros Melemenidis, DPhil, is a distinguished figure in the field of Radiation Oncology, currently serving as Director of Pre-clinical Radiotherapy and Research Scientist at Stanford University’s Department of Radiation Oncology in Stanford, CA, USA. He completed his DPhil in Radiation Biology at the University of Oxford, where his research focused on molecular targeted imaging methods for lung metastasis and angiogenesis detection. Dr. Melemenidis holds a diverse educational background including degrees from UCLA and the University of Liverpool. His expertise spans preclinical radiotherapy, ultra-high dose-rate irradiation experiments, and the development of advanced imaging probes and animal models for cancer research. Dr. Melemenidis is recognized for his contributions to radiation therapy and imaging sciences, employing innovative techniques to advance cancer treatment and research.

Professional Profile:

Scopus

🎓Education:

Stavros Melemenidis, DPhil, has pursued an extensive educational journey encompassing a diverse array of disciplines. He earned his DPhil in Radiation Biology from the University of Oxford, UK, focusing on the development of molecular targeted imaging methods for the detection of lung metastasis and angiogenesis. His academic credentials also include a Cert. in Medical Physics from UCLA, USA, an M.Sc. in Radiation Biology from the University of Oxford, UK, and an M.Sc. in Radiometrics; Instrumentation and Modelling from the University of Liverpool, UK. Dr. Melemenidis began his academic path with a B.Sc. in Physics: Medical Applications from the University of Liverpool and an A.Eng. in PC Systems and Peripheral Equipment from IIEK Neapoleos, Technical College, Greece. This diverse educational background has equipped him with expertise spanning radiation biology, medical physics, instrumentation, and modelling, contributing significantly to his research and leadership roles in the field of Radiation Oncology at Stanford University.

🏢Work Experience:

Stavros Melemenidis, DPhil, holds key positions in the field of Radiation Oncology at Stanford University in Stanford, CA, USA. Since January 2023, he has served as the Director of Pre-clinical Radiotherapy within the Department of Radiation Oncology, overseeing advanced research initiatives. Prior to this role, Dr. Melemenidis has been integral to the Division of Radiation Therapy as a Research Scientist since February 2020, contributing to innovative studies in radiation oncology. His earlier career includes impactful roles as a Postdoctoral Fellow at Stanford University from February 2016 to June 2020, where he focused on developing in vivo mouse tumor models and integrating imaging techniques with radiotherapy and immunotherapy. Previously, he was a Postdoctoral Fellow at the University of Oxford’s Department of Radiation Oncology from January 2015 to September 2015, conducting research on novel imaging probes for metastasis and angiogenesis detection. These experiences underscore Dr. Melemenidis’s dedication to advancing preclinical and clinical applications in radiation oncology through pioneering research and leadership.

Publication Top Notes:

  • Human enteroids as a tool to study conventional and ultra-high dose rate radiation
    • Authors: Klett, K.C., Martin-Villa, B.C., Villarreal, V.S., Loo Jr, B.W., Heilshorn, S.C.
    • Citations: 1
  • Real-time optical oximetry during FLASH radiotherapy using a phosphorescent nanoprobe
    • Authors: Ha, B., Liang, K., Liu, C., Loo, B.W., Pratx, G.
    • Citations: 4
  • Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension
    • Authors: Taylor, S., Isobe, S., Cao, A., Snyder, M.P., Rabinovitch, M.
    • Citations: 10
  • Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies
    • Authors: Jorge, P.G., Melemenidis, S., Grilj, V., Loo, B.W., Bailat, C.
    • Citations: 9